Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Advisory Committee Freeze Raises Concerns Of Delayed, More Controversial Approvals
Feb 10 2025
•
By
Sarah Karlin-Smith
and
Sue Sutter
The FDA's advisory committee calendar for 2025 is currently empty.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US Advisory Committees
More from Product Reviews